Anaphylaxis following the intravenous administration of continuous erythropoietin receptor activator in a haemodialysis patient.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | OH, DONG JIN | - |
dc.date.accessioned | 2022-07-16T04:47:22Z | - |
dc.date.available | 2022-07-16T04:47:22Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2014-05 | - |
dc.identifier.issn | 1320-5358 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/159958 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.title | Anaphylaxis following the intravenous administration of continuous erythropoietin receptor activator in a haemodialysis patient. | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | OH, DONG JIN | - |
dc.identifier.doi | 10.1111/nep.12213 | - |
dc.identifier.scopusid | 2-s2.0-84898986175 | - |
dc.identifier.wosid | 000334685700007 | - |
dc.identifier.bibliographicCitation | NEPHROLOGY, v.19, no.5, pp.304 - 304 | - |
dc.relation.isPartOf | NEPHROLOGY | - |
dc.citation.title | NEPHROLOGY | - |
dc.citation.volume | 19 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 304 | - |
dc.citation.endPage | 304 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | continuous erythropoiesis receptor activator | - |
dc.subject.keywordPlus | novel erythropoiesis stimulating protein | - |
dc.subject.keywordPlus | recombinant erythropoietin | - |
dc.subject.keywordPlus | antianemic agent | - |
dc.subject.keywordPlus | continuous erythropoiesis receptor activator | - |
dc.subject.keywordPlus | erythropoietin | - |
dc.subject.keywordPlus | macrogol derivative | - |
dc.subject.keywordPlus | anaphylactic shock | - |
dc.subject.keywordPlus | delayed hypersensitivity | - |
dc.subject.keywordPlus | drug half life | - |
dc.subject.keywordPlus | hemodialysis | - |
dc.subject.keywordPlus | hemoglobin blood level | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | letter | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | pruritus | - |
dc.subject.keywordPlus | skin test | - |
dc.subject.keywordPlus | anaphylaxis | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | chemically induced | - |
dc.subject.keywordPlus | drug hypersensitivity | - |
dc.subject.keywordPlus | Hypersensitivity, Immediate | - |
dc.subject.keywordPlus | intravenous drug administration | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | renal replacement therapy | - |
dc.subject.keywordPlus | time | - |
dc.subject.keywordPlus | treatment outcome | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/nep.12213 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.